Progression in Huntington’s linked to CAG repeat numberAugust 16, 2019Huntington's DiseaseMovement Disorders
Huntington’s symptom domains correlate with structural differencesJuly 16, 2019Huntington's DiseaseMovement Disorders
Novel genetic therapy reduces key protein in Huntington’s diseaseJune 12, 2019Huntington's DiseaseRare DiseasesNeuromuscular Disorders
Mutant huntingtin and neurofilament light are potential biomarkers in Huntington’s diseaseJune 11, 2019Rare DiseasesNeuromuscular DisordersHuntington's Disease
Laquinimod may not improve motor function in Huntington’s diseaseMay 6, 2019Huntington's DiseaseMovement Disorders
Polyglutamine diseases are rare, but not the mutations that cause themApril 4, 2019Rare DiseasesHuntington's Disease
Huntington’s research returns to Latin America, as scientists tread with careDecember 3, 2018Movement DisordersRare DiseasesHuntington's Disease
Huntington’s progression tracks with levels of mutant huntingtin, neurofilament lightSeptember 12, 2018Movement DisordersRare DiseasesHuntington's Disease
VIDEO: Encouraging results reported for novel Huntington’s disease therapyApril 23, 2018Movement DisordersHuntington's Disease
Gene silencer reduces mutant huntingtin protein in early-stage Huntington’s patientsDecember 12, 2017Movement DisordersRare DiseasesHuntington's Disease
Salivary biomarker identified for Huntington’s diseaseNovember 13, 2017Movement DisordersRare DiseasesHuntington's Disease
Austedo approved for treatment of tardive dyskinesiaAugust 31, 2017Movement DisordersHuntington's Disease
FDA approves deutetrabenazine for Huntington’s-associated choreaApril 4, 2017Movement DisordersRare DiseasesHuntington's Disease
Intermediate alleles may confer mild, late-onset Huntington-like symptomsJuly 21, 2016Movement DisordersRare DiseasesHuntington's Disease
Deutetrabenazine modestly reduces chorea of Huntington diseaseJuly 5, 2016Movement DisordersHuntington's Disease
